New lens aims to sharpen vision at all distances after cataract surgery

NCT ID NCT06446817

Recruiting now Disease control Sponsor: Cutting Edge SAS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new multifocal lens (LuxHighAdd) for cataract surgery, comparing it to a standard monofocal lens. About 57 people aged 50+ with cataracts in both eyes will receive the lens in both eyes. The goal is to see if the new lens improves near vision without harming distance vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multifocal intraocular lens (LuxHighAdd IOL)
What this could lead to: If successful, this lens could help people see clearly at multiple distances after cataract surgery, reducing the need for glasses.
What could go wrong: This is a small, early-stage trial with only 57 people. The lens may not provide better vision than standard lenses, and risks like glare or halos are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

Centre d'Ophtalmologie des Dr Rozot et associés
RECRUITING

Marseille, 13008, France
Clinique Honoré Cave
RECRUITING

Montauban, 82000, France
Hôpital Fondation Adolphe de Rothschild
RECRUITING

Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.